False-positive lysergic acid diethylamide immunoassay screen associated with fentanyl medication [6]

Clinical Chemistry

Volumn 48, Issue 1, 2002, Pages 205-206

  Gagajewski, A ^a   Davis, G K ^a   Kloss, J ^a   Poch, G K ^a   Anderson, C J ^a   Apple, F S ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL DERIVATIVE; LYSERGIDE;

ADULT; ANALYTIC METHOD; CASE REPORT; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; LETTER; MALE; SAMPLING; SCREENING; TOXICOLOGY; URINALYSIS;

EID: 0036137881     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.1.205     Document Type: Letter

References (7)

1. Metabolism of lysergic acid diethylamide (LSD) in human liver microsomes and cryopreserved human hepatocytes
2. Lysergic acid diethylamide (LSD)
3. Interference with testing for lysergic acid diethylamide
4. False-positive LSD testing in urine samples from intensive care patients
5. Detection and interpretation of lysergic acid diethylamide results by immunoassay screening of urine in various testing groups
6. Immunoassay analysis of lysergic acid diethylamide